EUVIMEDEUVIMED entdecken
Fallbericht

Positive neonatal screening test for congenital adrenal hyperplasia in a case with 3β-hydroxysteroid dehydrogenase type 2 deficiency

Merve Anik, Deniz Erdogan, Tugba Baris, Ilknur Arslanoglu, Aylin Tugba Canbaz, Tulay Guran iD

Journal of Pediatric Endocrinology and Metabolism · 2026

DOI: 10.1515/jpem-2025-0403 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, 2026. Verfasst von Merve Anik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Duzce University Faculty of Medicine, Duzce, Türkiye. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Neonatal Screening. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The neonatal CAH screening test is mainly performed for early detection of and avoidance of mortality due to salt-wasting crises related to severe 21-hydroxylase deficiency. 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2) deficiency is a rare subtype of CAH that leads to salt-wasting crises. To present a case of HSD3B2 deficiency with a positive neonatal CAH screening test, emphasizing the role of newborn screening in early diagnosis. Case presentation A 46,XY newborn who assigned female at birth, was admitted on the fifth postnatal day due to atypical genitalia. His neonatal CAH screening test subsequently resulted positive. Low cortisol and aldosterone levels, elevated adrenocorticotropic hormone (ACTH), hyponatremia, and hyperkalemia were detected. Steroid hormone profile suggested a diagnosis of HSD3B2 deficiency, and subsequent genetic testing revealed compound heterozygous variants in the HSD3B2 gene. Electrolyte balance was achieved with hydrocortisone and fludrocortisone replacement therapy.

Conclusions

The neonatal CAH screening test offers an extra advantage in guiding early diagnosis and treatment of patients with rare salt-wasting forms of CAH, such as HSD3B2 deficiency in countries where these conditions are relatively more common.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Hyperplasia, CongenitalNeonatal ScreeningHumansFemaleInfant, NewbornMaleProgesterone Reductase

Stichwörter der Autor:innen

3β-hydroxysteroid dehydrogenase deficiencyDSDatypical genitaliacongenital adrenal hyperplasiaprimary adrenal insufficiency

Substanzen

3 beta-hydroxysteroid dehydrogenase type IIProgesterone Reductase

Autor:innen und Institutionen

  • Department of Pediatric Endocrinology, Duzce University Faculty of Medicine, Duzce, Türkiye.
  • Gelisim Genetik Tani Merkezi, Istanbul, Türkiye.
  • Department of Pediatric Endocrinology, 64050 Marmara University Faculty of Medicine, Istanbul, Türkiye.

ORCID-Profile: Tulay Guran

Zitieren

APA

Anik, M., Erdogan, D., Baris, T., Arslanoglu, I., Canbaz, A. T., & Guran, T. (2026). Positive neonatal screening test for congenital adrenal hyperplasia in a case with 3β-hydroxysteroid dehydrogenase type 2 deficiency. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2025-0403

Vancouver

Anik M, Erdogan D, Baris T, Arslanoglu I, Canbaz AT, Guran T. Positive neonatal screening test for congenital adrenal hyperplasia in a case with 3β-hydroxysteroid dehydrogenase type 2 deficiency. Journal of Pediatric Endocrinology and Metabolism. 2026. doi:10.1515/jpem-2025-0403

BibTeX
@article{Anik2026,
  author = {Anik, Merve and Erdogan, Deniz and Baris, Tugba and Arslanoglu, Ilknur and Canbaz, Aylin Tugba and Guran, Tulay},
  title = {Positive neonatal screening test for congenital adrenal hyperplasia in a case with 3β-hydroxysteroid dehydrogenase type 2 deficiency},
  journal = {Journal of Pediatric Endocrinology and Metabolism},
  year = {2026},
  doi = {10.1515/jpem-2025-0403}
}
Kostenlos starten →